$1.45M raised. 13.16B $IPO sold. Not from marketing, from thousands deciding to go against the 1%. This community isn't here for easy conditions but for what gets built regardless of the market. We're building for retail and the 99%. Join: bit.ly/x-buy-ipogenie

The global private equity market is worth an estimated $3 trillion. Yet less than 1% is directly accessible to retail investors. IPO Genie is building infrastructure designed to change that, powered by $IPO. The $IPO presale is closing soon. Join today: bit.ly/x-buy-ipogenie

In 1999, the median U.S. company went public in 4 years. By 2024, it was 14 years. The public markets used to get the growth story. Not anymore. IPO Genie aims to give access to you at the beginning of the journey. $IPO presale closing soon, join today: bit.ly/x-buy-ipogenie

Inflation: 3–4%. Savings: ~4.5%. S&P 500 historical average: ~10%. The real question isn’t whether to invest. It’s where. $IPO unlocks access to high-potential pre-IPO opportunities evaluated across 100+ touchpoints. Invest for what comes next: bit.ly/x-buy-ipogenie

Everything moves onchain eventually.

4 hours left to buy $IPO at $0.0002127. This price doesn't come back. 652% still separates today's entry from the listing price. In four hours, that gap gets smaller, permanently, and every token still available at this price is gone. Buy $IPO today: bit.ly/x-buy-ipogenie

Your brokerage app holds 0% private markets allocation. Not because the category doesn't perform but because the infrastructure to offer it to individual retail investors directly has never existed. IPO Genie changes that. Join today: bit.ly/ig-buy-ipogenie

Most retail investors have never actually looked at a cap table, and it's costing them the ability to evaluate a deal properly. A cap table is simply a record of who owns what percentage of a company, but every funding round dilutes the holders before it, founders, early employees, seed investors, Series A and B VCs, each new round shrinking what came before. By the time a company IPOs, the earliest investors may hold just 10-20% of their original stake. That sounds like a loss until you see the other side of it, because if the valuation grew 1,000x, a diluted 10% stake still nets 100x. Understanding the cap table isn't academic. It's the difference between knowing whether your position is actually worth protecting or already worth nothing. Join the platform today: bit.ly/x-buy-ipogenie

4 hours left at $0.0002104. This price doesn't come back once it's gone. The presale moves on a fixed schedule, and every phase closes exactly on time, no extensions, no second chances, no dip back down to where you are right now. What's available at this price is only available for the next four hours. After that, the number changes, and everyone who didn't act is buying in at whatever comes next. Buy $IPO now: bit.ly/x-buy-ipogenie

12 hours left at $0.0002104. The presale runs on a fixed 48-hour clock, and this window is more than halfway closed. Half a day is enough time to actually think it through, check the numbers, decide if this fits what you're building toward. It's not enough time for the price to wait around while you do. Join today: bit.ly/x-buy-ipogenie

The average retail investor earns roughly 1.4% annually on their portfolio. Over that same period, the S&P 500 itself returns closer to 10.5%. That's not a small gap, it's a difference that compounds into an entirely different financial life over twenty or thirty years, and it has almost nothing to do with the market failing anyone. The index did exactly what it was supposed to do. The gap comes from behavior, panic selling during downturns, chasing whatever's already run up, jumping in and out based on headlines instead of a plan, missing the best days in the market because fear pulled money out right before a rebound. The market was never the problem. How people react to it is. With IPO Genie, you don't have to guess, we give you the winners and we give you access to real pre-IPO and high conviction deals. Join the platform today: bit.ly/x-buy-ipogenie

A new phase is LIVE 🧞 Current price: $0.0002104 Listing target: $0.0016 660% between today's entry and listing. Every phase on this curve runs on the same fixed clock, no exceptions, no early access to yesterday's number once today's has taken its place. The gap to listing is still substantial from here, and it only gets smaller from this point forward, whether or not you're the one holding a position when it does. The price steps up every 48 hours. This phase is open now. Join the presale: bit.ly/x-buy-ipogenie

Warren Buffett is stepping down as Berkshire Hathaway chair. "I have never felt better about what comes next," he said in a letter to shareholders.

We Didn't Build IPO Genie Because We Guessed Right. We Built It Because the Direction Was Obvious. Yesterday's SEC decision on tokenized stocks wasn't a surprise to us. It was the moment the rest of the market caught up to a thesis we've been building on since day one: tokenized assets are moving on-chain, and the winners will be the platforms that got the infrastructure right before regulators forced everyone else to. Billions in capital are about to move onchain, and the window to be early instead of late just started closing. Q4 2026 is when our platform ships, and the presale for $IPO, our token which powers the platform, is open now for anyone who wants access to true private market investment deals. The price increases every 48 hours. Join the presale before it's too late: bit.ly/x-ipogenie

The SEC Just Validated What IPO Genie is building! The SEC gave the official green light today for trading platforms to offer tokenized US stocks, real shares on a blockchain, with full shareholder rights and no fake price-tracking wrappers allowed, effective immediately. This is a huge win for the entire tokenized ownership space, and a solid confirmation of exactly what we're building at IPO Genie. Real ownership for pre-IPO and high conviction deals, on-chain, made accessible. This is confirmation that our promise to retail consumers is much more than just perps for OpenAI or synthetic exposure to Anthropic. We're building real dealflow for tokenized equity, for the 99%, and we're launching Q4 2026. Billions of dollars are about to pour into crypto off the back of this move. Banks, exchanges, consumers, everyone is going to go all in. Tokenization is no longer a theory, the SEC just made it the proof. We saw this coming, planned for it and built it early. That's our moat now. Join the presale today: bit.ly/x-ipogenie

The SEC Just Formalized the Product We're Building. Real Ownership, Not Synthetic Wrappers. The SEC issued an order creating a five-year "Innovation Exemption," a blanket regulatory pathway that lets qualifying trading venues list and trade tokenized versions of US-listed stocks without registering as a full exchange. It takes effect immediately. Token holders must retain the same rights as traditional shareholders, and the exemption explicitly excludes synthetic tokens, the kind that just track a price without conferring real ownership. Companies also get the right to object to having their own shares tokenized. This isn't a shortcut around securities law. It's the SEC building a real onramp for exactly the model tokenized pre-IPO and equity-access platforms are built on: on-chain instruments that represent actual equity, not a synthetic bet on it. For a platform built on the idea that tokenized ownership should replace paper claims in private and public markets alike, this isn't a tailwind. It's the regulator confirming the model. bit.ly/x-ipogenie

The SEC cleared a path for trading venues to offer tokenized stocks in the U.S., a landmark decision that may overhaul traditional equity markets on.wsj.com/4xyksuH

The average millionaire is commonly said to run seven separate income streams at once, not one job carrying the entire load. Four of those seven are investment-based: private equity and pre-IPO access, stocks and dividends, real estate, and crypto staking and yield. The other three, digital business, specialized skills, and partnerships, matter too, but it's the investment side that keeps compounding without needing more hours in the day. Look closely at that list and one category stands out as the hardest to actually build without institutional access. Private equity and pre-IPO exposure has always required accreditation, minimum check sizes, and relationships most retail investors were never going to have. Stocks, real estate, even crypto staking, all reachable with a normal account and enough patience. That one pillar has been structurally locked out. IPO Genie exists to put that stream back within reach. Join the presale: bit.ly/x-buy-ipogenie

Research on how the average millionaire builds wealth consistently points to the same pattern, seven separate income streams, not one job and one paycheck. Four of those seven are investment-based: private equity and pre-IPO access, stocks and dividends, real estate, and crypto staking and yield. The other three, online business, specialized skills, and partnerships, matter too, but it's the investment side that compounds without requiring more hours in the day. Most retail portfolios are missing an entire category from that list. Private equity and pre-IPO access were never realistically available outside of accredited investors and institutional allocators, which meant an entire pillar of how wealth actually gets built was structurally off-limits. That's the piece IPO Genie adds back in. Join the presale: bit.ly/x-buy-ipogenie

A new phase is LIVE 🧞 Current price: $0.0002092 Expected Launch: Q4 2026 665% between today's entry and listing. Every price on this curve only exists once. Not a discount that reappears next month, not a level the chart dips back down to if you wait it out, a single window that closes permanently the moment the next phase begins. What's available right now will never be available again at this number, regardless of what happens to the project after. This presale runs on that structure by design. The price steps up every 48 hours. This phase is open now. Join today: bit.ly/x-buy-ipogenie